Vireo Growth (VREOF) EBT (2020 - 2026)
Vireo Growth's (VREOF) quarterly EBT came in at -$4.2 million in Q1 2026, up 12.5% year-on-year from -$3.7 million in Q1 2025, and up 65.13% quarter-over-quarter from -$12.0 million in Q4 2025.
Vireo Growth (VREOF) EBT (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed EBT across 7 years of filings, most recently posting -$4.2 million for Q1 2026.
- EBT for Q1 2026 came in at -$4.2 million, up 12.5% year-over-year; the trailing twelve-month figure through Mar 2026 was -$39.3 million (down 107.51% YoY), and the FY2025 annual result was -$39.9 million, down 136.24% from the prior year.
- EBT came in at -$4.2 million for Q1 2026 at Vireo Growth, up from -$12.0 million in the prior quarter.
- In the past five years, EBT ranged from a high of -$228411.0 in Q2 2024 to a low of -$16.3 million in Q1 2022.
- The 5-year median for EBT is -$5.7 million (2023), against an average of -$6.8 million.
- Across the five-year window, EBT jumped 96.02% in 2024 and tumbled 4313.11% in 2025, its largest moves.
- Vireo Growth's EBT stood at -$7.3 million in 2022, then jumped by 51.0% to -$3.6 million in 2023, then sank by 215.97% to -$11.4 million in 2024, then retreated by 6.05% to -$12.0 million in 2025, then jumped by 65.13% to -$4.2 million in 2026.
- The last three EBT figures came in at -$4.2 million (Q1 2026), -$12.0 million (Q4 2025), and -$13.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 437.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 758.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 318.30 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 17.47 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 246.80 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 87.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -61.93 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 156.41 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -101.55 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn | -4.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.20 Mn |
| Dec 31, 2025 | -12.05 Mn |
| Sep 30, 2025 | -12.95 Mn |
| Jun 30, 2025 | -10.08 Mn |
| Mar 31, 2025 | -4.80 Mn |
| Dec 31, 2024 | -11.36 Mn |
| Sep 30, 2024 | -2.54 Mn |
| Jun 30, 2024 | -228,411.00 |
| Mar 31, 2024 | -2.77 Mn |
| Dec 31, 2023 | -3.59 Mn |
| Sep 30, 2023 | -1.75 Mn |
| Jun 30, 2023 | -5.74 Mn |
| Mar 31, 2023 | -6.74 Mn |
| Dec 31, 2022 | -7.34 Mn |
| Sep 30, 2022 | -7.78 Mn |
| Jun 30, 2022 | -5.14 Mn |
| Mar 31, 2022 | -16.31 Mn |
| Dec 31, 2021 | -11.78 Mn |
| Sep 30, 2021 | -6.31 Mn |
| Jun 30, 2021 | -6.10 Mn |